BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2340487)

  • 1. Cytogenetic analysis of 54 cases of myelodysplastic syndrome.
    Jotterand-Bellomo M; Parlier V; Schmidt PM; Beris P
    Cancer Genet Cytogenet; 1990 Jun; 46(2):157-72. PubMed ID: 2340487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
    Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
    Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic survey of 117 Tunisian patients with de novo myelodysplastic syndrome.
    Sendi HS; Hichri H; Elghezal H; Gribaa M; Laatiri A; Elloumi M; Ben Lakhal R; Saad A
    Ann Genet; 2002; 45(3):131-5. PubMed ID: 12381443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
    Gmidène A; Sennana H; Fenaux P; Laatiri A; Zarrouk M; Bouaziz H; Harrabi I; Saad A
    Leuk Res; 2008 Dec; 32(12):1824-9. PubMed ID: 18556065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 11 abnormalities in myelodysplastic syndromes.
    Collado R; Badía L; García S; Sánchez H; Prieto F; Carbonell F
    Cancer Genet Cytogenet; 1999 Oct; 114(1):58-61. PubMed ID: 10526536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
    Suciu S; Kuse R; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
    Vila L; Charrin C; Archimbaud E; Treille-Ritouet D; Fraisse J; Felman P; Fiere D; Germain D
    Blut; 1990 Apr; 60(4):223-7. PubMed ID: 2337681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
    Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
    Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
    de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
    Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
    Jacobs RH; Cornbleet MA; Vardiman JW; Larson RA; Le Beau MM; Rowley JD
    Blood; 1986 Jun; 67(6):1765-72. PubMed ID: 3708160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic analysis of bone marrow from patients with primary myelodysplastic syndrome.
    Wu HK; Kitamura K; Xi YR; Wang YT; Liu SL; Zhou DB
    J Int Med Res; 1992 Jun; 20(3):254-66. PubMed ID: 1397670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromosome abnormalities in myelodysplastic syndrome].
    Fujita K; Mori H; Niikura H; Terada H; Shinohara T
    Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes.
    Knapp RH; Dewald GW; Pierre RV
    Mayo Clin Proc; 1985 Aug; 60(8):507-16. PubMed ID: 3860707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.